A scientific misconduct and related topics: a letter from Russia

Sergei V. Jargin


Letter to Editor


Scientific misconduct, plagiarism, publication

Full Text:



von Elm E. Research integrity: collaboration and research needed. Lancet 370:1403-1404, 2007.

Vlasov VV. Emerging problems of medical ethics in Russia:medical practice and research. Kardiologiia 42:81-84, 2002.

Gordon AG. Never cite sight unseen. Am J Obstet Gynecol 178:627, 1998.

Jargin SV. Overestimation of Chernobyl conse-quences: poorly substantiated information published. Radiat Environ Biophys 49:743-745, 2010.

Severgina ES, Pal’tsev MA. Hypoplastic dysplasia as one of the forms of nephropathy. Arkh Patol 51:58-63, 1989.

Severgina LO, Gurevich SI. Ultrastructural assessment of the role of dysangiogenesis in congenital hydronephrosis. Arkh Patol 76:51-55, 2014.

Asai A, Okita T, Enzo A. Conflicting messages concerning current strategies against research misconduct in Japan:a call for ethical spontaneity. J Med Ethics 42:524-527, 2016.

Iargin SV. The message about unreliability of publications. Klin Khir 6:69-70, 2011.

Jargin SV. Development of antiatherosclerotic drugs on the basis of cell models. Int J Pharmacol Phytochem Ethnomed 1:10-14, 2015.

Jargin SV. On the endoscopic methods used with questionable indications. J Surgery 4:6, 2016.

Jargin SV. Invasive procedures with questionable indications. Ann Med Surg 3:126-129, 2014.

Jargin SV. Some aspects of renal biopsy for research. Int J Nephrol Kidney Failure 1:8, 2015.

Jargin SV. About the treatment of gonorrhea in the former Soviet Union. Dermatol Pract Concept 2:12, 2012.

Smith R. Research misconduct: The poisoning of the well. J R Soc Med 99:232-237, 2006.

Jargin SV. Pathology in the former Soviet Union:scientific misconduct and related phenomena. Dermatol Pract Concept 1:75-81, 2011.

Jargin SV. On the use of carnosine and antioxidants:A letter from Russia. J Intercult Ethnopharmacol 5:317-319, 2016.

Babalola O, Grant-Kels JM, Parish LC. Ethical dilemmas in journal publication. Clin Dermatol 30:231-236, 2012.

Cowell HR. Ethical responsibilities of editors, reviewers, and authors. Clin Orthop Relat Res 378:83-89, 2000.

Jargin SV. Alcohol consumption by Russian workers before and during the economical reforms of the 1990s. Int J High Risk Behav Addic 2:48-50, 2013.

Glybochko PV. Treatment optimization of benign prostatic hyperplasia combined with senile osteoporosis. Doctoral dissertation. Saratov, 2001. (in Russian)

Jargin SV. Series of papers on scientific misconduct. Dermatol Pract Concept 13(1):20, 2007 continued in 13(3), 2007; 14(2), 2008; 15(1, 2, 4); 2009, 2010; and 16(1-3), 2010.

Felinescu Kitty, Jargin SV. What has changed in Russian pathology since the fifties? Abstract PP1-240. Abstracts of the 21st European Congress of Pathology, September 8-13, 2007, Istanbul. Virchows Archiv 451:270, 2007.

Omutov M, Jargin SV. The practice of pathology in Russia. Abstract PP-262. Abstracts of the 21st European Congress of Pathology, September 8-13, 2007, Istanbul. Virchows Archiv 451:277, 2007.

Nikolaeva LI, Toichuev PM, Leibman EA, Grishechkin AE, Omorbekova ChT, Akhmedova DP, Khametova MSh, Rakhimova GM, Jargin SV, Uchaikin VF. Factors influencing on the course of chronic hepatitis C in children. Epidemiol Vakcinoprofil 6:37-44, 2013.

Chistiakov DA, Orekhov AN, Bobryshev YV. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability. Acta Physiol 213:539-553, 2015.

Chazov EI, Tertov VV, Orekhov AN, Lyakishev AA, Perova NV, Kurdanov KA, Khashimov KA, Novikov ID, Smirnov VN. Atherogenicity of blood serum from patients with coronary heart disease. Lancet 2:595-598, 1986.

Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN. Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis 60:101-110, 1986.

Orekhov AN, Baldenkov GN, Tertov VV, Ryong LH, Kozlov SG, Lyakishev AA, Tkachuk VA, Ruda MYa, Smirnov VN. Cardiovascular drugs and atherosclerosis:effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol 12 Suppl 6:S66-S68, 1988.

Orekhov AN, Pivovarova EM, Sobenin IA, Yakushkin VV, Tertov VV. Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil. Drugs 44 Suppl 1:105-110, 1992.

Orekhov AN, Tertov VV, Pivovarova EM. The effect of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells. Cardiology 89: 111-118, 1998.

Orekhov AN, Sobenin IA, Orekhova VA, Mel'nichenko AA, Miasoedova VA, Mukhamedova NM, Martirosian DM, Pshezhetskiĭ AV, Karagodin VP. Cultured cell systems for revelation of new drugs antiatherosclerotic effects and their mechanisms investigation. Patol Fiziol Eksp Ter 1:33-39, 2012.

Orekhov AN, Sobenin IA, Korneev NV, Kirichenko TV, Myasoedova VA, Melnichenko AA, Balcells M, Edelman ER, Bobryshev YV. Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov 8:56-66, 2013.

Orekhov AN, Melnichenko AA, Sobenin IA. Approach to reduction of blood atherogenicity. Oxid Med Cell Longev 2014:738679, 2014.

Reng LC, Vasil'ev AV, Orekhov AN., Tutel'ian VA. Anti-atherosclerotic properties of eicosapentaenoic acid:clinico-experimental study. Vopr Pitan 3:20-22, 1989.

Ryong LH, Tertov VV, Vasil'ev AV, Tutel'yan VA, Orekhov AN. Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture. Drug Dev Res 17:109-117, 1989.

Sobenin IA, Andrianova IV, Demidova ON, Gorchakova T, Orekhov AN. Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study. J Atheroscler Thromb 15:334-338, 2008.

Sobenin IA, Pryanishnikov VV, Kunnova LM, Rabinovich YA, Martirosyan DM, Orekhov AN. The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis 9:119, 2010.

Sobenin IA, Chistiakov D.A., Bobryshev Y.V., Orekhov AN. Blood atherogenicity as a target for anti-atherosclerotic therapy. Curr Pharm Des 19:5954-5962, 2013.

Tertov VV, Orekhov AN, Martsenyuk ON, Perova NV, Smirnov VN. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol 50:337-347, 1989.

Jargin SV. Cell culture as a testing system for anti-atherogenic substances:a brief communication. Acta Pharmaceutica Sciencia 50:237-240, 2008.

Jargin SV. Testing of serum atherogenicity on cell cultures:assessment of reliability. Gazz Med Ital 170:159-163, 2011.

Jargin SV. Orekhov’s method:reassessment of in vitro lipid uptake assays. Recent Pat Cardiovasc Drug Discov 9:122-125, 2015.

Jargin SV. Food supplement Development in Russia on the Basis of Cell Culture Experiments. Austin J Nutri Food Sci 3:1069, 2015.

Aksenov D, Orekhova D, Kireev R, andrianova I, Smirnov A, Sobenin I, Panasenko O. Effects of sex hormones on intracellular cholesterol accumulation and LDL aggregation. Abstract PO2-11. Abstracts of the 77th Congress of the European Atherosclerosis Society, 26-29 April 2008, Istanbul. Atheroscler Suppl 9:20, 2008.

Jargin SV. Barriers to the importation of medical products to Russia:in search of solutions. Healthcare in Low-resource Settings 1:e13, 2013


  • There are currently no refbacks.